Bora Pharmaceuticals Announces Subsidiary Endorsement Guarantees Reach 78.11% of Net Worth

Bora Pharmaceuticals announced that as of May 11, 2026, its total endorsement guarantee balance for subsidiaries has reached TWD 12.01 billion, representing 78.11% of the company's net worth. The guarantees involve 100% owned subsidiaries including Bora Biologics USA and Upsher-Smith Laboratories. These measures primarily support CDMO operational asset acquisitions and provide financing credit lines, facilitating the group's global expansion in the pharmaceutical manufacturing and services sector.